BROWN BROTHERS HARRIMAN & CO
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 14661
NEW YORK, NY
Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,606,900
+$558,620 QoQ
Shares Held
5,838
+29.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BROWN BROTHERS HARRIMAN & CO holds $9,680,711 across 45 Biotechnology names. VRTX ranks #1 (26.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5,838 | $2,606,900 | |
| 2 | PCVX |
Vaxcyte, Inc.
|
38,033 | $2,210,097 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
15,000 | $1,458,750 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,802 | $1,392,297 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
39,973 | $360,156 | |
| 6 | TECH |
BIO-TECHNE Corp
|
6,724 | $351,396 | |
| 7 | MRNA |
Moderna, Inc.
|
6,843 | $347,624 | |
| 8 | INCY |
Incyte Corp
|
1,937 | $182,310 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,606,900 | 5,838 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,048,280 | 4,518 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,221,525 | 3,119 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,300,874 | 2,922 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,372,040 | 2,830 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,144,473 | 2,842 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,152,468 | 2,478 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,173,674 | 2,504 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,003,224 | 2,400 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,022,921 | 2,514 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $939,941 | 2,703 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $922,004 | 2,620 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $796,496 | 2,528 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $712,997 | 2,469 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $717,769 | 2,479 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $694,048 | 2,463 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $631,286 | 2,419 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $512,766 | 2,335 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $482,860 | 2,662 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $547,022 | 2,713 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $617,808 | 2,875 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $817,972 | 3,461 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $93,609 | 344 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $99,866 | 344 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $114,929 | 483 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||